Lutetium-177 Treatment Cost in India

What is the Cost of Lutetium-177 PSMA Therapy in India

Lutetium-177 PSMA Therapy Costs in India start from 9800 USD per course. A course on average, and a patient receiving lutetium-177 PSMA therapy will typically receive three or four courses. Lu-177 therapies, such as PSMA and PRRT therapy, are typically recommended to fourth-stage cancer patients after all other therapeutic options have been exhausted. These medicines improve patients’ health and standard of life, resulting in significantly higher survival rates.

However, the overall Nuclear Medicine Therapy Cost in India starts from USD. The Treatment cost plan may differ from person to person and type of hospital chosen by the patient.

How Does Lutetium-177 PSMA Therapy Work

PSMA is a protein that is generated on the membrane of prostate cells and is believed to have a variety of biological activities. Although the prostatic epithelium produces very small amounts of PSMA normally, malignant prostate tumors produce extremely large amounts (sometimes 1,000 times more than a normal prostate cell). PSMA will be identified if prostate cancer has spread to other parts of the body. 

Lutetium-177 is a radioactive material that emits beta radiation, which is a type of damaging radiation. Lutetium-177 binds to a short peptide that attaches to the PSMA receptor found on the surface of cancer cells. The Lutetium-177 PSMA complex, once attached to the prostate cancer cell, emits destructive radiation, causing the cancer cell to die. Because the released beta particle has a very low penetration, the surrounding normal cells are undisturbed.

Procedure

Before the Procedure:

• Patients are not required to do fasting or make any other preparations before undergoing diagnostic imaging or therapy infusion. 
• The nuclear medicine team will provide all necessary supporting care to the patient.

During the Procedure:

• On an average week later, the team will follow up the PET scan with the lutetium-177 PSMA, another injectable radioactive element that specifically targets the cancer that was detected on the PET scan.  
• To administer the medication, an IV is inserted into the patient’s arm; the injection takes only a few minutes. Patients are observed for one to two hours before sending them to home.
• A doctor would normally check on patients every three weeks to screen for side effects, which may include extracting blood.
•  If you’re doing well and reacting well, we’ll continue with the therapy.  The treatments are once every six weeks for a total of six treatments.

After the Procedure:

• Most patients go through three to four therapy cycles at 8-12 week intervals. Depending on the response and interim evaluations, the number of cycles and interim time may differ between individuals. 
• The average dose of Lu PSMA Therapy in India provided per treatment is in the range of 5.5-11GBq, and the doses are based on pre-treatment dosimetry (Dosimetry is the measurement, computation, and assessment of the ionizing radiation dose received by the human body).
• View your PDF report on what to do in the two to three days following therapy to ensure the patient’s and family’s safety. 

Helpful – Best Nuclear Medicine Hospitals in India

What are the Benefits of Lutetium-177 PSMA Therapy in India?

This therapy improves the quantity and quality of life for patients who would otherwise have few treatment alternatives. Most patients who are suitable for this therapy are already suffering from cancer-related symptoms that are affecting their quality of life. As the majority of patients respond to the medication, their symptoms improve and their quality of life improves. It’s also well tolerated, thus from a risk/benefit and quality of life standpoint, this medication is highly effective.

How can Medsurge India Help

Medsurge India is a prestigious support system for patients looking for doctors, hospitals, and specialized treatments. We’ll find the most suitable medical options for you. Regarding your medical issues, our team will give you a list of certified, reputable, and trusted doctors and hospitals. Additionally, we offer a treatment strategy that fits your budget. Apart, we assist patients with obtaining travel authorizations, medical visas, and a multitude of other things.

Q: What are the disadvantages of lutetium-177?

A: Although Lu-177 PSMA therapy is considered safe because the dose of Lutetium-177 radiation is carefully checked for each patient prior to treatment, some adverse effects might be predicted, including an increased risk of bleeding, Nausea,  Dry Mouth.

Q: Who is a candidate for lutetium-177 PSMA therapy in the treatment of prostate cancer?

A: You may be eligible if you have prostate cancer that has gone beyond the prostate and has progressed despite prior treatments (including hormonal therapies and at least one chemotherapy).

Q: How is lutetium recovered?

A: The mineral monazite, like many other lanthanides, is the primary source of lutetium. It is extracted by reducing anhydrous fluoride with calcium metal, which is a challenging process.

Q: Is lutetium safe?

A: Ingestion of lutetium is mildly hazardous, however its insoluble salts are non-toxic. Lutetium, like other rare-earth metals, has a low toxicity rating, although it and its derivatives should be handled with caution.

Q: Does lutetium-177 work?

A: Lutetium-177 therapy is only used on men who have prostate cancer and have exhausted all other treatment options. It has been shown to be a successful medication for treating metastatic prostate cancer or prostate cancer after other treatments have failed.